<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Determinants of peak VO2 in heart transplant recipients</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Sociedade Brasileira de Cirurgia Cardiovascular</publisher>
				<availability status="unknown"><p>Copyright Sociedade Brasileira de Cirurgia Cardiovascular</p>
				</availability>
				<date type="published" when="2014">2014</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vitor</forename><forename type="middle">Oliveira</forename><surname>Carvalho</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guilherme</forename><forename type="middle">Veiga</forename><surname>Guimãres</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marcelo</forename><forename type="middle">Luiz Campos</forename><surname>Vieira</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Aparecida</forename><forename type="middle">Maria</forename><surname>Catai</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP (InCor HC-FMUSP)</orgName>
								<address>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Vagner</forename><surname>Oliveira-Carvalho</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP (InCor HC-FMUSP)</orgName>
								<address>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Silvia</forename><forename type="middle">Moreira</forename><surname>Ayub-Ferreira</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edimar</forename><forename type="middle">Alcides</forename><surname>Bocchi</surname></persName>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Departamento de Fisioterapia da Universidade Federal de São Carlos -UFScar</orgName>
								<orgName type="department" key="dep2">Departamento de Fisiotera-pia da Universidade Federal de Sergipe (UFS)</orgName>
								<orgName type="laboratory">Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP (InCor HC-FMUSP)</orgName>
								<address>
									<settlement>São Paulo, São Carlos, Aracaju</settlement>
									<region>SE</region>
									<country>Brazil, Brazil, Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Federal de Sergipe (UFS)</orgName>
								<orgName type="department" key="dep2">Departamento de Fisioterapia/Hospital</orgName>
								<orgName type="institution" key="instit1">Universidade</orgName>
								<orgName type="institution" key="instit2">Universitário</orgName>
								<address>
									<addrLine>Rua Cláudio Batista , sn -Aracaju</addrLine>
									<region>SE</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Determinants of peak VO2 in heart transplant recipients</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Revista Brasileira de Cirurgia Cardiovascular</title>
						<idno type="ISSN">0102-7638</idno>
						<imprint>
							<publisher>Sociedade Brasileira de Cirurgia Cardiovascular</publisher>
							<date type="published" when="2014" />
						</imprint>
					</monogr>
					<idno type="DOI">10.5935/1678-9741.20140055</idno>
					<idno type="PMID">25859862</idno>
					<idno type="PMCID">PMC4389529</idno>
					<note type="submission">received on December 3 rd , 2013 Article accepted on February 24 th , 2014</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-14T00:55+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>To establish the determinants of the peak VO 2 in heart transplant recipients. Methods: Patient&apos;s assessment was performed in two consecutive days. In the first day, patients performed the heart rate variability assessment followed by a cardiopulmonary exercise test. In the second day, patients performed a resting echocardiography. Heart transplant recipients were eligible if they were in a stable condition and without any evidence of tissue rejection diagnosed by endomyocardial biopsy. Patients with pacemaker, noncardiovascular functional limitations such as osteoarthritis and chronic obstructive pulmonary disease were excluded from this study. Results: Sixty patients (68% male, 48 years and 64 months following heart transplantation) were assessed. Multivariate analysis selected the following variables: receptor&apos;s gender (P=0.001), receptor age (P=0.049), receptor Body Mass Index (P=0.005), heart rate reserve (P&lt;0.0001), left atrium diameter (P=0.016). Multivariate analysis showed r=0.77 and r2=0.6 with P&lt;0.001. Equation: peakVO 2 =32.851-3.708 (receptor gender)-0.067 (receptor age)-0.318 (receptor BMI) + 0.145 (heart rate reserve)-0.111 (left atrium diameter).</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion:</head><p>The determinants of the peak VO 2 in heart transplant recipients were: receptor sex, age, Body Mass Index, heart rate reserve and left atrium diameter. Heart rate reserve was the unique variable positively associated with peak VO 2 . This data suggest the importance of the sympathetic reinnervation in peak VO 2 in heart transplant recipients.</p><p>Descriptors: Heart Transplantation. Exercise. Exercise Tolerance.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Resumo Objetivo: Estabelecer os determinantes do VO 2 pico em transplantados de coração.</head><p>Métodos: Avaliação do paciente foi realizada em dois dias consecutivos. No primeiro dia, os pacientes realizaram a avaliação da variabilidade da frequência cardíaca seguida de um teste de esforço cardiopulmonar. No segundo dia, os pacientes realizaram ecocardiografia de repouso. Os transplantados foram elegíveis se estivessem em uma condição estável e sem qualquer evidência de rejeição diagnosticada por biópsia endomiocárdica. Pacientes com marca-passo, limitações funcionais não cardiovasculares,</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Heart transplantation is a worldwide procedure indicated to patients with refractory heart failure. It is well known that heart transplant improves patient's survival, quality of life and exercise capacity, when compared to pre-transplant condition <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b3">2]</ref> .</p><p>Although heart transplant recipients have an exercise capacity greater than before the procedure, it is known that the physical capacity restoration to normal levels does not always occur <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b3">2]</ref> . This is attributed to physical deconditioning resulting from previous heart failure <ref type="bibr" target="#b4">[3]</ref> , a low chronotropic response (as a result of a cardiac denervation, also accessed by heart rate variability) <ref type="bibr" target="#b5">[4]</ref> and, in many cases, impairment in cardiac function after transplantation <ref type="bibr" target="#b3">[2]</ref> . The cardiac systolic function of the transplanted heart seems to be normal in most patients, while diastolic dysfunction appears to be present in most of the transplanted heart. Diastolic dysfunction was recently identified as one of the factors that seem to influence negatively the maximal and submaximal exercise capacity in heart transplant recipients <ref type="bibr" target="#b6">[5,</ref><ref type="bibr" target="#b7">6]</ref> . Despite this, little is known about the determinants of exercise capacity in heart transplant recipients.</p><p>The aim of this study was to establish the determinants of the peak VO 2 in heart transplant recipients.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design</head><p>This study was performed in a tertiary cardiology hospital in Brazil. Patient's assessment was performed in two con-tais como osteoartrite e doença pulmonar obstrutiva crônica foram excluídos deste estudo.</p><p>Resultados: Sessenta pacientes (68% do sexo masculino, 48 anos e 64 meses após o transplante cardíaco) foram avaliados. A análise multivariada selecionou as seguintes variáveis: sexo (P=0,001), idade (P=0,049), Índice de Massa Corporal (P=0,005), frequência cardíaca de reserva (P&lt;0,0001), diâmetro do átrio esquerdo (P=0,016), variáveis do receptor. A análise multivariada mostrou r=0,77 e r2=0,6, com P&lt;0,001. Equação: VO 2 =32,851 -3,708 (sexo receptor) -0,067 (idade receptor) -0,318 (IMC receptor) + 0,145 (frequência cardíaca de reserva) -0,111 (diâmetro de átrio esquerdo).</p><p>Conclusão: Os determinantes do pico de VO 2 em transplantados de coração foram: sexo receptor, idade, Índice de Massa Corporal, frequência cardíaca de reserva e diâmetro do átrio esquerdo. A frequência cardíaca de reserva foi a única variável positivamente associada com o pico de VO 2 . Estes dados sugerem a importância da reinervação simpática no pico de VO 2 em transplantados de coração. Oxygen consumption secutive days. In the first day, patients performed the heart rate variability assessment followed by a cardiopulmonary exercise test. In the second day, patients performed a resting echocardiography.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study population</head><p>Heart transplant recipients were eligible if they were in a stable condition (for, at least, 3 months) and without any evidence of tissue rejection diagnosed by endomyocardial biopsy. Patients with pacemaker, noncardiovascular functional limitations such as osteoarthritis and chronic obstructive pulmonary disease were excluded from this study. Patients were recruited from a tertiary cardiology hospital from September 2010 to November 2011. Subjects' characteristics are listed in <ref type="table" target="#tab_1">Table 1</ref>.</p><p>This protocol was approved by the Ethical Committee of our institution. All patients provided informed consent prior to participation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Variables considered to be potentially associated with peak VO 2</head><p>We considered to be potentially associated with peak VO 2 as follows: donor and recipient age and body mass index (BMI), etiology of heart failure before transplantation (Chagas and non-Chagas), recipient heart rate reserve, gender, percentage of age-predicted peak heart rate, percentage of heart rate drop in the second minute of recovery in the cardiopulmonary test, left atrium diameter, cold ischemia time, time following heart transplantation, resting heart rate, VE/ VCO 2 slope, right ventricle diameter, left ventricle diastolic diameter, left ventricle ejection fraction, E/E' ratio and low/ high frequency domain in heart rate variability (LF/HF). </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cardiopulmonary exercise test</head><p>All patients were asked to refrain from both strenuous physical activity and the consumption of any stimulants (e.g., coffee, tobacco, alcohol) for 24h prior to the cardiopulmonary exercise test. Patients' last meal was ingested at least 2h before the test. Heart transplant recipients underwent the test on a programmable treadmill (TMX425 Stress Treadmill; TrackMaster, Newton, KS, USA) in a temperature-controlled room (21-23°C) between 10-12am with a standard 12-lead continuous ECG monitor (CardioSoft 6.5; GE Medical Systems IT, Milwaukee, WI, USA). Blood pressure monitoring was performed by an automatic device. Resting heart rate was considered the 20-min average in a supine position. Minute ventilation, oxygen uptake, carbon dioxide output and other cardiopulmonary variables were acquired breath-by-breath by a computerized system (Vmax Encore29; SensorMedics, Yorba Linda, CA, USA).</p><p>Metabolic data were computed as the mean of the final 30 s of the resting period, whereas peak of VO 2 and peak heart rate were the mean values of the final 30 s of effort before exhaustion. The respiratory exchange ratios were recorded as the averaged samples obtained during each stage of a modified Naughton protocol. A satisfactory cardiopulmonary exercise test was characterized by a peak of respiratory exchange ratio&gt;1.05 and symptoms of maximum effort. Heart rate reserve [bpm] was defined as maximum heart rate achieved in the cardiopulmonary exercise test -average of 10-min resting heart rate in the supine position. Heart rate recovery was assessed during the first and second minutes after cardiopulmonary exercise test.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Echocardiography</head><p>The assessment followed the recommendations of the American Society of Ecocardiography <ref type="bibr" target="#b8">[7]</ref> . We used a commercially available equipment, model IE 33, Philips Medical Systems, Andover, MA, USA. The acquired data considered bidimensional echocardiography, pulsed Doppler, continuous wave Doppler, tissue Doppler and color flow mapping. It was obtained at least three measurements of each echocardiographic variable and the average was considered. We analyzed: left ventricle diameters and volumes, left ventricle ejection fraction (Simpson's rule), left ventricle mass index, left ventricle diastolic assessment (pulsed Doppler of mitral inflow and the study of the flow of pulmonary veins and Tissue Doppler). Thus, we analyzed with pulsed Doppler, E and A waves, E/A ratio, deceleration time (DT), isovolumic relaxation time (IVRT), systolic component of the pulmonary venous flows (S wave), diastolic component of the pulmonary venous flow (D wave), S/D ratio. The analysis with tissue Doppler was obtained in apical four and two chambers with sample volume of 1 to 2 mm. It was checked to the maximum rate of myocardial displacement at the beginning and end of the diastole (E' and A' wave respectively) and during systole (S' wave) at the septal ring, side ring, bottom ring, front ring of right ventricle. Measurement of E/E´ratio was performed in the left ventricular annulus, from the basal septal and lateral segments (considered mean values).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Heart rate variability</head><p>Experimental protocol: All the heart transplant recipients remained at rest for 10 minutes on the supine position and were instructed to breathe spontaneously. Then, instantaneous R-R intervals (RRi) were recorded for 10 min with a digital telemetry system, consisting of a transmitter placed on the patient's chest and a HR monitor (Polar  RS800CX; Polar Electro Oy, Kempele, Finland) This system detects ventricular depolarization, corresponding to the R wave on the electrocardiogram, at a sampling rate of 500 Hz, which had been previously validated <ref type="bibr" target="#b9">[8]</ref> . The signals were transmitted to a receiver and then to a computer for subsequent analysis. Data analysis: The RRi sequence of length n=256 beats was selected for each subject. The length of greatest stability was chosen from the central region of the time series. The mean and variance of the RRi were also calculated. HRV spectral analysis: The HRV frequency domain analysis was performed with an autoregressive model <ref type="bibr" target="#b10">[9,</ref><ref type="bibr" target="#b11">10]</ref> , on previously selected RRi sequences. Two main spectral components were considered: low frequency (LF -from 0.04 to 0.15 Hz) and high frequency (HF -from 0.15 to 0.50 Hz) that represent the sympathetic and vagal modulations, respectively <ref type="bibr">[11]</ref> . The spectral components are reported as normalized units (LFun and HFun) and LF/HF ratio. Normalization consisted of dividing the power of a given spectral component (HF or LF) by the total power minus the power below 0.04 Hz, and multiplying the ratio by 100.9 All patients presented a respiratory rate in the frequency range of HF band of HRV.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Current medication intake</head><p>Medication profile is shown in <ref type="table" target="#tab_1">Table 1</ref>. Patients took angiotensin conversor enzyme inhibitors, losartan and isosorbide 5-mononitrate two times per day, one half of the daily dose in the morning (9:00 am) and the other half at night (9:00 pm). Diuretics were taken in the morning (9:00 am). All heart transplant recipients were receiving immunosuppressive therapy two times per day, one half of the daily dose in the morning and the other half at night. Antihypertensive drugs were taken, most of the times, in the morning.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>Data are presented as mean and standard deviation. We evaluated the association of the variables collected in the 60 selected patients. For this, we used univariate analysis to select the variables to be used in the multivariate model. For the univariate analysis, a significance level of less than 20% (P&lt;0.20) was considered. In multivariate analysis, the nonsignificant variables were excluded from the model (manual-ly, one at a time) following the criterion of greater "P" value. The model was determined when all the variables were presented with a significance level less than 5% (P&lt;0.05). The dependent variable used was the peak VO 2 <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b3">2,</ref><ref type="bibr" target="#b6">5]</ref> . After the analysis, we established an equation with variables associated with peak VO 2 .</p><p>For all statistical analyzes, we used SPSS (Chicago IL, USA) version 13.0.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Participants</head><p>From 176 heart transplant recipients alive in our service, 109 were not found by phone calls or lived in another city that prevented the realization of the protocol. Seven patients were excluded due to refusal, pacemaker or sequel of stroke <ref type="figure" target="#fig_0">(Figure 1</ref>). Sixty patients (68% male, 48 years and 64 months following heart transplantation) were assessed ( <ref type="table" target="#tab_1">Table 1)</ref>.</p><p>Multivariate analysis selected the following variables: receptor's gender (P=0.001), receptor age (P=0.049), receptor BMI (P=0.005), heart rate reserve (P&lt;0.0001), left atrium diameter (P=0.016). Multivariate analysis showed r=0.77 and r2=0.6 with P&lt;0.001.</p><p>Equation derived from the multivariate analysis: peak VO 2 =32,851 -receptor gender (3,708) -receptor age (0,067) -receptor BMI (0,318) + heart rate reserve (0,145) -left atrium diameter (0,111)</p><p>Considering: peak VO 2 in mL/Kg/min, gender (0=male and 1=female), age in years, BMI in Kg/m 2 , heart rate reserve in beats per minute and left atrium diameter in millimeters.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>The main finding of this study was that peak VO 2 of heart transplant recipients was determined by receptor gender, age, BMI, heart rate reserve and left atrium diameter.</p><p>Our study is the first one to investigate the determinants of peak VO 2 in heart transplant recipients using variables that are non-invasive and easy to be collected in clinical practice.</p><p>In our study, we observed that the peak VO 2 was negatively associated with gender, BMI and age of the recipient and the diameter of the left atrium of the allograft. Of these, gender and BMI seemed to be the determinants more strongly associated with exercise capacity. Moreover, the heart rate reserve was the unique variable positively associated to peak VO 2 .</p><p>Our data strongly suggest that the sympathetic reinnervation is the main variable that positively influences peak VO 2 in heart transplant recipients. Nevertheless, the parasympathetic reinnervation does not seem to influence the exercise capacity in heart transplant recipients. Previous studies showed that the parasympathetic reinnervation in adults is not consistent and may occur only from 5 to 10% of cases. Moreover, the sympathetic reinnervation occurs much more frequently and is related to exercise capacity in heart transplant recipients from 50 to 60% of cases in 3 years <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b12">12,</ref><ref type="bibr" target="#b13">13]</ref> . The study by Bernardi et al. <ref type="bibr" target="#b14">[14]</ref> showed that exercise training can improve cardiovascular control in heart transplant recipients.</p><p>The negative influence of BMI, age and gender in exercise capacity is already well established in exercise physiology field. It is known that women have lower peak VO 2 than men, as well as fatter people compared to skinny and older people compared to younger, when we keep all other variables (such as exercise training levels) constant <ref type="bibr" target="#b15">[15]</ref> .</p><p>A relatively new data appeared in our research: the negative influence of the left atrium diameter in peak VO 2 in heart transplant recipients. The study by Abdul-Waheed et al. <ref type="bibr" target="#b16">[16]</ref> showed that the left atrium of adult heart transplant recipients increased in one year of follow-up. Moreover, this study showed an inverse association between left atrium and peak VO 2 . The authors hypothesized that the surgical scar could be negatively influ- Outcome data/main results Univariate analysis selected the following variables: receptor's age (P=0.042), receptor's BMI (P=0.056), heart rate reserve (P&lt;0.0001), percentage of age-predicted peak heart rate (P=0.052), percentage of heart rate drop in the second minute of recovery in the cardiopulmonary exercise test (P=0.067), slope VE/VCO 2 (0.115), left atrium diameter (P=0.028), right ventricular diameter (P=0.079), E/E' ratio (0.144), cold ischemia time (P=0.15), donor's age (P=0.022), LF/HF (P=0.18) and receptor's sex (P=0.003). The following variables were withdrawn from multivariate analysis model (in order of withdrawal): slope VE/VCO 2 (P=0.957), percentage of heart rate drop in the second minute of recovery in the cardiopulmonary exercise test (P=0.937), percentage of age-predicted peak heart rate (P=0.771), right ventricle diameter (P=0.456), LF / HF (P=0.434), donor's age (P=0.51), cold ischemia time (P=0.227) and E/E' ratio (P=0.449).</p><p>encing left atrium pumping. In agreement with Abdul-Waheed et al. <ref type="bibr" target="#b16">[16]</ref> , our study showed a similar relationship between left atrium and exercise capacity. Unfortunately, our study can not explain the mechanisms involved in this relationship, but the hypothesis raised by Abdul-Waheed at al. <ref type="bibr" target="#b16">[16]</ref> seems to be relevant and deserves a deep investigation in future studies.</p><p>The lack of influence of the time of transplant and the E/E' ratio in peak VO 2 found in this study is an important information and deserves some discussion. The E/E' ratio is an important echocardiography index in the diagnosis of diastolic dysfunction and has been shown to be related to functional class, cardiac mortality and hospitalization in patients with heart failure <ref type="bibr" target="#b17">[17,</ref><ref type="bibr" target="#b18">18]</ref> . The ratio above 15 is a strong indicator of heart failure with preserved left ventricle ejection fraction. The E/E' ratio between 8 and 15 represents a "gray zone" for diagnosis of diastolic dysfunction. In these cases, B-type Natriuretic Peptide (BNP) seem to have a great importance for the differential diagnosis <ref type="bibr" target="#b19">[19]</ref> .</p><p>The prevalence of diastolic dysfunction in our study was 3.4%, which we consider low compared to 33% of the study by Roten et al. <ref type="bibr" target="#b6">[5]</ref> We expected that the prevalence of diastolic dysfunction were higher and the E/E' ratio increased along the segment after heart transplantation due to the increased incidence of co-morbidities such as hypertension. There are no data in the literature regarding diastolic function (E/E' ratio) and time of cardiac transplantation. We believe the fact that our patients are well treated and compensated for comorbidities such as hypertension, the E/E' ratio remained constant throughout the follow-up. In a curious way, our study showed no association between peak VO 2 and the time of transplantation, but a positive association between peak VO 2 and cardiac sympathetic reinnervation through heart rate reserve. These data are quite relevant for a deeper understanding of the behavior of exercise capacity over time of transplantation. It seems that the real factor influencing exercise capacity is sympathetic reinnervation and not simply the time of transplantation. This information let us believe that for the same time following heart transplant, we will have more and less reinnervated patients. Consequently we will have patients with higher and lower exercise capacity.</p><p>Finally, the study by Roten et al. <ref type="bibr" target="#b6">[5]</ref> showed that the diastolic dysfunction was associated with exercise capacity limitation of heart transplant recipients. However, our study found no such association. Because of this conflicting data, some considerations must be taken into account. In our study, the prevalence of diastolic dysfunction was much lower than in the study by Roten et al. <ref type="bibr" target="#b6">[5]</ref> Perhaps if our study had shown a higher prevalence of diastolic dysfunction (and consequent higher E/E' ratio), our data would have agreed to the study by Roten et al. <ref type="bibr" target="#b6">[5]</ref> Therefore, further studies in this area are necessary for a deeper understanding of the relationship between peak VO 2 and the E/E' ratio.</p><p>This study has some limitations. Patients only performed resting echocardiography. Certainly, the assessment of the cardiac function during exercise would bring important information to the understanding of the relationship between E/E' ratio and in exercise capacity of heart transplant recipients. In addition, further investigation of the left atrium would be relevant for a better understanding of the mechanisms involved in the limitation of exercise capacity. This study was also limited by not assessing the vascular function and peripheral muscle metabolism (oxygen extraction). Tests such as the kinetics of O 2 , would be useful in future research to evaluate the influence of the "periphery" in the exercise capacity of transplanted patients.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSION</head><p>In this study, the determinants of the peak VO 2 in heart transplant recipients were: receptor gender, age, BMI, heart rate reserve and left atrium diameter. Heart rate reserve was the unique variable that was positively associated with peak VO 2 . This data suggest the importance of the sympathetic reinnervation in peak VO 2 in heart transplant recipients.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' roles &amp; responsibilities</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>VOC</head><p>Analysis and/or interpretation of data, statistical analysis, final approval of the manuscript, conception and design of the study, implementation of operations and/or experiments, manuscript writing or critical review of its content GVG Analysis and/or interpretation of data, final approval of the manuscript, design and study design, performance of operations and/or experiments MLCV Analysis and/or interpretation of data, final approval of the manuscript, current operations and/or experiments, manuscript writing or critical review of its content AMC analysis and/or interpretation of data, final approval of the manuscript, current operations and/or experiments, manuscript writing or critical review of its content VOC Analysis and/or interpretation of data, final approval of the manuscript, design and study design, performance of operations and/or experiments, manuscript writing or critical review of its content SMAF Analysis and/or interpretation of data, final approval of the manuscript, current operations and/or experiments EAB Analysis and/or interpretation of data, final approval of the manuscript, design and study design, performance of operations and/or experiments, manuscript writing or critical review of its content.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 -</head><label>1</label><figDesc>Patients flow throughout the study.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Descritores: Transplante de Coração. Exercício. Aptidão Física. Abbreviations, acronyms &amp; symbols</head><label></label><figDesc></figDesc><table><row><cell>BMI</cell><cell>Body mass index</cell></row><row><cell>BNP</cell><cell>B-type Natriuretic Peptide</cell></row><row><cell>DT</cell><cell>Deceleration time</cell></row><row><cell>ECA</cell><cell>Angiotensin conversor enzyme inhibitors</cell></row><row><cell>IVRT</cell><cell>Isovolumic relaxation time</cell></row><row><cell>LF/HF</cell><cell>Low/high frequency domain in heart rate variability</cell></row><row><cell>RRi</cell><cell>R-R intervals</cell></row><row><cell>VO 2</cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc>Characterization of study participants. Carvalho VO, et al. -Determinants of peak VO 2 in heart transplant recipients</figDesc><table><row><cell>Variables</cell><cell>Number of patients (%), dose(mg/day)</cell></row><row><cell>Etiology:</cell><cell></cell></row><row><cell>Chagas (%)</cell><cell>45%</cell></row><row><cell>Non-Chagas (%)</cell><cell>55%</cell></row><row><cell>Men (%)</cell><cell>68%</cell></row><row><cell>Recipients age (years)</cell><cell>48±15</cell></row><row><cell>Donors age (years)</cell><cell>31±11</cell></row><row><cell>Donors weight (kg)</cell><cell>76±9</cell></row><row><cell>Recipients weight (kg)</cell><cell>68±13</cell></row><row><cell>Donors height (cm)</cell><cell>176±7</cell></row><row><cell>Recipients height (cm)</cell><cell>166±10</cell></row><row><cell>Ischemic time (min)</cell><cell>206±115</cell></row><row><cell>Recipients BMI (Kg/m 2 )</cell><cell>25±4</cell></row><row><cell>Donors BMI (Kg/m 2 )</cell><cell>25±2</cell></row><row><cell>Time following heart transplant (months)</cell><cell>64±54</cell></row><row><cell>Resting heart rate (bpm)</cell><cell>82±12</cell></row><row><cell>Recipients heart rate reserve (bpm)</cell><cell>49±17</cell></row><row><cell>% of age-predicted peak heart rate</cell><cell>77±12</cell></row><row><cell>% of heart rate drop in the second minute of recovery</cell><cell>8±8</cell></row><row><cell>Left atrium diameter</cell><cell>44±10</cell></row><row><cell>Cold ischemia time (min)</cell><cell>207±115</cell></row><row><cell>VE/VCO 2 slope</cell><cell>30±6</cell></row><row><cell>Right ventricle diameter (mm)</cell><cell>22±3</cell></row><row><cell>Left ventricle diastolic diameter (mm)</cell><cell>48±4</cell></row><row><cell>Left ventricle ejection fraction (%)</cell><cell>62±5</cell></row><row><cell>E/E' ratio</cell><cell>6.8±2.3</cell></row><row><cell>LF/HF</cell><cell>6.9±8.9</cell></row><row><cell>Medication:</cell><cell></cell></row><row><cell>Cyclosporine</cell><cell>71%, 174±58 mg/day</cell></row><row><cell>Diuretics</cell><cell>8.3%</cell></row><row><cell>ACE inhibitors (enalapril)</cell><cell>10%, 23±14 mg/day</cell></row><row><cell>Angiotensin receptor antagonist (losartan)</cell><cell>10%, 62±31 mg/day</cell></row><row><cell>Corticosteroids (prednisone)</cell><cell>30%, 5.2±3.4 mg/day</cell></row><row><cell>Azathioprine</cell><cell>30%, 76±25 mg/day</cell></row><row><cell>Mycophenolate</cell><cell>37%, 1096±422 mg/day</cell></row><row><cell>Tacrolimus</cell><cell>25%, 7±4 mg/day</cell></row><row><cell>Sirolimus</cell><cell>1.6%, 1 mg/day</cell></row><row><cell>Everolimus</cell><cell>3.3%, 1±0.35 mg/day</cell></row><row><cell>Calcium channel blocker (diltiazem)</cell><cell>58%, 126±71 mg/day</cell></row><row><cell>Ezetimibe</cell><cell>1.6%, 10 mg/day</cell></row><row><cell>Simvastatin</cell><cell>68.3%,11.4±4.4 mg/day</cell></row><row><cell>Hydralazine</cell><cell>6.6%, 144±116 mg/day</cell></row><row><cell>Metformin</cell><cell>6.6%,1700±00 mg/day</cell></row><row><cell>Fluoxetine</cell><cell>3.3%, 32±11 mg/day</cell></row><row><cell>Gabapentin</cell><cell>1.6%, 400 mg/day</cell></row><row><cell>Olanzapine</cell><cell>5%, 10 mg/day</cell></row><row><cell>Topiramate</cell><cell>3.3%, 125±106 mg/day</cell></row><row><cell>Bromazepam</cell><cell>5%, 3 mg/day</cell></row><row><cell>Insulin</cell><cell>7.5%, 69±53 mg/day</cell></row><row><cell cols="2">BMI=Body mass index, ECA=Angiotensin conversor enzyme inhibitors. LF/HF=Low/high frequency domain in</cell></row><row><cell>heart rate variability</cell><cell></cell></row></table><note></note></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Effect of Sympathetic Reinnervation on Cardiac Performance after Heart Transplantation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><forename type="middle">M</forename><surname>Bengel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Ueberfuhr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nina</forename><surname>Schiepel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephan</forename><forename type="middle">G</forename><surname>Nekolla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bruno</forename><surname>Reichart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Markus</forename><surname>Schwaiger</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa010519</idno>
		<idno type="PMID">11547742</idno>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="731" to="738" />
			<date type="published" when="2001-09-06" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Braz J Cardiovasc Surg | Rev Bras Cir Cardiovasc Braz J Cardiovasc Surg</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="9" to="15" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Determinants of peak VO2 in heart transplant recipients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vitor</forename><forename type="middle">Oliveira</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guilherme</forename><forename type="middle">Veiga</forename><surname>Guimãres</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marcelo</forename><forename type="middle">Luiz Campos</forename><surname>Vieira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aparecida</forename><forename type="middle">Maria</forename><surname>Catai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vagner</forename><surname>Oliveira-Carvalho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Silvia</forename><forename type="middle">Moreira</forename><surname>Ayub-Ferreira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edimar</forename><forename type="middle">Alcides</forename><surname>Bocchi</surname></persName>
		</author>
		<idno type="DOI">10.5935/1678-9741.20140055</idno>
		<idno type="PMID">25859862</idno>
		<idno type="PMCID">PMC4389529</idno>
	</analytic>
	<monogr>
		<title level="j">Revista Brasileira de Cirurgia Cardiovascular</title>
		<idno type="ISSN">0102-7638</idno>
		<imprint>
			<date type="published" when="2014" />
			<publisher>Sociedade Brasileira de Cirurgia Cardiovascular</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Clinical predictors of exercise capacity 1 year after cardiac transplantation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tat-Chi</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karla</forename><forename type="middle">V</forename><surname>Ballman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">G</forename><surname>Allison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean</forename><forename type="middle">A</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lyle</forename><forename type="middle">J</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">P</forename><surname>Frantz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brooks</forename><forename type="middle">S</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><forename type="middle">A</forename><surname>Dearani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">C</forename><surname>Daly</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><forename type="middle">G A</forename><surname>Mcgregor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">J</forename><surname>Rodeheffer</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1053-2498(02)00475-8</idno>
		<idno type="PMID">12531409</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Heart and Lung Transplantation</title>
		<title level="j" type="abbrev">The Journal of Heart and Lung Transplantation</title>
		<idno type="ISSN">1053-2498</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="16" to="27" />
			<date type="published" when="2003-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Exercise capacity after heart transplantation: influence of donor and recipient characteristics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">G</forename><surname>Renlund</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">O</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">D</forename><surname>Ensley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>O'connell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">M</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Bristow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Heart Lung Transplant</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="16" to="24" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
	<note>Pt 1</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Effect of Sympathetic Reinnervation on Cardiac Performance after Heart Transplantation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><forename type="middle">M</forename><surname>Bengel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Ueberfuhr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nina</forename><surname>Schiepel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephan</forename><forename type="middle">G</forename><surname>Nekolla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bruno</forename><surname>Reichart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Markus</forename><surname>Schwaiger</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa010519</idno>
		<idno type="PMID">11547742</idno>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="731" to="738" />
			<date type="published" when="2001-09-06" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Diastolic Dysfunction of the Cardiac Allograft and Maximal Exercise Capacity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Roten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J-P</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Merz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Carrel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zwahlen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Walpoth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Mohacsi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Hullin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.healun.2008.12.001</idno>
		<idno type="PMID">19416770</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Heart and Lung Transplantation</title>
		<title level="j" type="abbrev">The Journal of Heart and Lung Transplantation</title>
		<idno type="ISSN">1053-2498</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="434" to="439" />
			<date type="published" when="2009-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Cardiovascular responses to incremental and sustained submaximal exercise in heart transplant recipients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jessica</forename><forename type="middle">M</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ben</forename><forename type="middle">T A</forename><surname>Esch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">J</forename><surname>Haykowsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Darren</forename><forename type="middle">E R</forename><surname>Warburton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mustafa</forename><surname>Toma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anwar</forename><surname>Jelani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dylan</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ian</forename><surname>Paterson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Delores</forename><surname>Poppe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuanyuan</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpheart.01100.2008</idno>
		<idno type="PMID">19060120</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Physiology-Heart and Circulatory Physiology</title>
		<title level="j" type="abbrev">American Journal of Physiology-Heart and Circulatory Physiology</title>
		<idno type="ISSN">0363-6135</idno>
		<idno type="ISSNe">1522-1539</idno>
		<imprint>
			<biblScope unit="volume">296</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="H350" to="H358" />
			<date type="published" when="2009-02" />
			<publisher>American Physiological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><forename type="middle">M</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luigi</forename><forename type="middle">P</forename><surname>Badano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wendy</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">H</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eustachio</forename><surname>Agricola</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><surname>Buck</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francesco</forename><forename type="middle">F</forename><surname>Faletra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><surname>Franke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Judy</forename><surname>Hung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leopoldo</forename><surname>Pérez De Isla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Otto</forename><surname>Kamp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaroslaw</forename><forename type="middle">D</forename><surname>Kasprzak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrizio</forename><surname>Lancellotti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">H</forename><surname>Marwick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marti</forename><forename type="middle">L</forename><surname>Mcculloch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">J</forename><surname>Monaghan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Petros</forename><surname>Nihoyannopoulos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Natesa</forename><forename type="middle">G</forename><surname>Pandian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patricia</forename><forename type="middle">A</forename><surname>Pellikka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mauro</forename><surname>Pepi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">A</forename><surname>Roberson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stanton</forename><forename type="middle">K</forename><surname>Shernan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Girish</forename><forename type="middle">S</forename><surname>Shirali</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lissa</forename><surname>Sugeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Folkert</forename><forename type="middle">J</forename><surname>Ten Cate</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mani</forename><forename type="middle">A</forename><surname>Vannan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jose</forename><forename type="middle">Luis</forename><surname>Zamorano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">A</forename><surname>Zoghbi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.echo.2011.11.010</idno>
		<idno type="PMID">22183020</idno>
		<ptr type="open-access" target="https://www.zora.uzh.ch/id/eprint/75298/1/EurHeartCardImaging_201201.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of the American Society of Echocardiography</title>
		<title level="j" type="abbrev">Journal of the American Society of Echocardiography</title>
		<idno type="ISSN">0894-7317</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="3" to="46" />
			<date type="published" when="2012-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Accuracy of a novel real-time microprocessor QRS detector for heart rate variability assessment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Loimaala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Sievänen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Laukkanen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Pärkkä</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Vuori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Huikuri</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2281.1999.00152.x</idno>
		<idno type="PMID">10068870</idno>
		<idno type="ark">ark:/67375/WNG-RT2M4K3N-X</idno>
		<idno type="istexId">AB69C85BE79771F2D8B3CB063AE680911D899F5D</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Physiology</title>
		<idno type="ISSN">0144-5979</idno>
		<idno type="ISSNe">1365-2281</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="84" to="88" />
			<date type="published" when="1999-02" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Cardiovascular neural regulation explored in the frequency domain.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Malliani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pagani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Cerutti</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.84.2.482</idno>
		<idno type="PMID">1860193</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.84.2.482" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="482" to="492" />
			<date type="published" when="1991-08" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pagani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Guzzetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Rimoldi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Furlan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Pizzinelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation Res</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="1043" to="65" />
			<date type="published" when="1986" />
		</imprint>
	</monogr>
	<note>Circulation.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Heart Rate Variability After Cardiac Transplantation in Humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dirk</forename><surname>Ramaekers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hugo</forename><surname>Ector</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Johan</forename><surname>Vanhaecke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Johan</forename><surname>Cleemput</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frans</forename><surname>Werf</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1540-8159.1996.tb03286.x</idno>
		<idno type="PMID">8994951</idno>
		<idno type="ark">ark:/67375/WNG-41R48123-M</idno>
		<idno type="istexId">FC0A77D8C383E975F96F8CC8D8D9EAB1EAC0965D</idno>
	</analytic>
	<monogr>
		<title level="j">Pacing and Clinical Electrophysiology</title>
		<title level="j" type="abbrev">Pacing Clin Electro</title>
		<idno type="ISSN">0147-8389</idno>
		<idno type="ISSNe">1540-8159</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2112" to="2199" />
			<date type="published" when="1996-12" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>Pt 1</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Regional differences in sympathetic reinnervation after human orthotopic cardiac transplantation.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">F</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">D</forename><surname>Laxson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">V</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">L</forename><surname>Mcginn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Kubo</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.88.1.165</idno>
		<idno type="PMID">8319329</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.88.1.165" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="165" to="171" />
			<date type="published" when="1993-07" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Effects of physical training on cardiovascular control after heart transplantation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luciano</forename><surname>Bernardi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><surname>Radaelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Claudio</forename><surname>Passino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Colomba</forename><surname>Falcone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carla</forename><surname>Auguadro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luigi</forename><surname>Martinelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mauro</forename><surname>Rinaldi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><surname>Viganò</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giorgio</forename><surname>Finardi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijcard.2006.07.032</idno>
		<idno type="PMID">17050012</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cardiology</title>
		<title level="j" type="abbrev">International Journal of Cardiology</title>
		<idno type="ISSN">0167-5273</idno>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="356" to="362" />
			<date type="published" when="2007-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Exercise Standards for Testing and Training: A Statement for Healthcare Professionals From the American Heart Association</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">F</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">J</forename><surname>Balady</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Amsterdam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Chaitman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Eckel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Fleg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">F</forename><surname>Froelicher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">S</forename><surname>Leon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">L</forename><surname>Pina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Rodney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Simons-Morton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Bazzarre</surname></persName>
		</author>
		<idno type="DOI">10.1161/hc3901.095960</idno>
		<idno type="PMID">11581152</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/hc3901.095960" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1694" to="1740" />
			<date type="published" when="2001-10-02" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Does left atrial volume affect exercise capacity of heart transplant recipients?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mohammad</forename><surname>Abdul-Waheed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mian</forename><surname>Yousuf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephanie</forename><forename type="middle">J</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ross</forename><surname>Arena</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Ying</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tehmina</forename><surname>Naz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephanie</forename><forename type="middle">H</forename><surname>Dunlap</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yukitaka</forename><surname>Shizukuda</surname></persName>
		</author>
		<idno type="DOI">10.1186/1749-8090-5-113</idno>
		<idno type="PMID">21083921</idno>
		<idno type="PMCID">PMC3000397</idno>
		<ptr type="open-access" target="https://cardiothoracicsurgery.biomedcentral.com/track/pdf/10.1186/1749-8090-5-113" />
	</analytic>
	<monogr>
		<title level="j">Journal of Cardiothoracic Surgery</title>
		<title level="j" type="abbrev">J Cardiothorac Surg</title>
		<idno type="ISSNe">1749-8090</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">113</biblScope>
			<date type="published" when="2010-11-17" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Tissue Doppler Imaging in Patients with Advanced Heart Failure: Relation to Functional Class and Prognosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ashraf</forename><surname>Hamdan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yaron</forename><surname>Shapira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tuvia</forename><surname>Bengal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mali</forename><surname>Mansur</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mordehay</forename><surname>Vaturi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaqueline</forename><surname>Sulkes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Battler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alex</forename><surname>Sagie</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.healun.2005.09.002</idno>
		<idno type="PMID">16446223</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Heart and Lung Transplantation</title>
		<title level="j" type="abbrev">The Journal of Heart and Lung Transplantation</title>
		<idno type="ISSN">1053-2498</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="214" to="218" />
			<date type="published" when="2006-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Prognostic implications of tissue Doppler in patients with dilated cardiomyopathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Galrinho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Branco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Soares</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Timóteo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Abreu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Leal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Port Cardiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="781" to="93" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Sociedade Brasileira de Cardiologia. III Brazilian Guidelines on Chronic Heart Failure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Bocchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">G</forename><surname>Braga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">E</forename><surname>Rohde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Oliveira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Almeida</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arq Bras Cardiol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="3" to="70" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
	<note>Suppl 1</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
